ASMANEX

This brand name is authorized in Austria, Canada, Germany, Spain, Finland, France, Hong Kong, Ireland, Japan, New Zealand, Poland, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug ASMANEX contains one active pharmaceutical ingredient (API):

1 Mometasone UNII 04201GDN4R - MOMETASONE FUROATE

Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade. Read about Mometasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ASMANEX TWISTHALER Inhalation powder	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03BA07	Mometasone	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02243595, 02243596, 02438690
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02735450, 02735510
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 65226, 65236
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 007516, 007549
Country: FR	Base de données publique des médicaments	Identifier(s): 60268519, 69337532
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 40439, 40444, 40459, 40461
Country: HK	Department of Health Drug Office	Identifier(s): 51293, 51294
Country: JP	医薬品医療機器総合機構	Identifier(s): 2290703G1020, 2290703G2026
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8952, 8953
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100130892, 100195437
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68206001, W68206002, W68207001, W68207002, W68207003
Country: SG	Health Sciences Authority	Identifier(s): 11277P, 11278P, 13630P
Country: US	FDA, National Drug Code	Identifier(s): 0085-1341, 0085-1461, 0085-2222, 0085-4333, 0085-4334
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/21.5.1/0343, 34/21.5.1/0344